This inventor holds 4 USPTO granted patents. Top assignee: The Rockefeller University. Active years: 2000-2002.
Company Filing History:
Years Active: 2000-2002
Title: The Innovations of Robert G. Roeder
Introduction
Robert G. Roeder is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of molecular biology and biochemistry, holding a total of 4 patents. His work primarily focuses on recombinant expression systems and histone acetyltransferase inhibitors.
Latest Patents
Roeder's latest patents include a system for the rapid generation of recombinant baculovirus-based expression vectors for silkworm larvae. This innovative system allows for the efficient production of proteins, particularly utilizing the nuclear polyhedrosis virus (BmNPV) with an efficiency approaching 100%. In a specific example, the vector was used to generate expression of a FLAG-epitope tagged HIV tat interacting protein of 30 kDa (f-TIP30) in BmN cells and silkworm larvae. Another notable patent involves inhibitors of histone acetyltransferases (HATs) that differentiate between p300 and PCAF histone acetyltransferase. This patent also outlines therapeutic processes for administering these inhibitors to humans.
Career Highlights
Throughout his career, Roeder has worked at prestigious institutions, including The Rockefeller University. His research has significantly advanced the understanding of protein production and gene expression.
Collaborations
Roeder has collaborated with notable colleagues such as Joseph D. Fondell and Chao Xingyuan, contributing to various research projects and innovations in his field.
Conclusion
Robert G. Roeder's contributions to molecular biology and biochemistry through his patents and research have had a lasting impact on the scientific community. His innovative approaches continue to influence the development of new therapeutic strategies and expression systems.